BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 27298564)

  • 1. Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients.
    Zhou XY; Li M; Li X; Long X; Zuo XL; Hou XH; Cong YZ; Li YQ
    World J Gastroenterol; 2016 Jun; 22(22):5211-27. PubMed ID: 27298564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
    Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
    Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroacupuncture Relieves Irritable Bowel Syndrome by Regulating IL-18 and Gut Microbial Dysbiosis in a Trinitrobenzene Sulfonic Acid-Induced Post-Inflammatory Animal Model.
    Song YF; Pei LX; Chen L; Geng H; Yuan MQ; Xu WL; Wu J; Zhou JY; Sun JH
    Am J Chin Med; 2020; 48(1):77-90. PubMed ID: 31918565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of water extracts from Cynanchum thesioides (Freyn) K. Schum. on visceral hypersensitivity and gut microbiota profile in maternally separated rats.
    Lingpeng P; Jingzhu S; Wei L; Enqi W; Yaqin L
    J Ethnopharmacol; 2021 Jan; 264():113352. PubMed ID: 32891821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of altered gut microbiota on visceral hypersensitivity of postinfectious irritable bowel syndrome mice.
    Cheng F; Fan Z; Lin C; Zhu Y; He H; Dai N; Du L
    Eur J Gastroenterol Hepatol; 2022 Dec; 34(12):1220-1230. PubMed ID: 36165068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome.
    Ren TH; Wu J; Yew D; Ziea E; Lao L; Leung WK; Berman B; Hu PJ; Sung JJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G849-56. PubMed ID: 17110521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota.
    Crouzet L; Gaultier E; Del'Homme C; Cartier C; Delmas E; Dapoigny M; Fioramonti J; Bernalier-Donadille A
    Neurogastroenterol Motil; 2013 Apr; 25(4):e272-82. PubMed ID: 23433203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paneth Cell Defects Induce Microbiota Dysbiosis in Mice and Promote Visceral Hypersensitivity.
    Riba A; Olier M; Lacroix-Lamandé S; Lencina C; Bacquié V; Harkat C; Gillet M; Baron M; Sommer C; Mallet V; Salvador-Cartier C; Laurent F; Théodorou V; Ménard S
    Gastroenterology; 2017 Dec; 153(6):1594-1606.e2. PubMed ID: 28865734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
    Li G; Yang M; Jin Y; Li Y; Qian W; Xiong H; Song J; Hou X
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1220-1226. PubMed ID: 29194775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression Promotes the Onset of Irritable Bowel Syndrome through Unique Dysbiosis in Rats.
    Takajo T; Tomita K; Tsuchihashi H; Enomoto S; Tanichi M; Toda H; Okada Y; Furuhashi H; Sugihara N; Wada A; Horiuchi K; Inaba K; Hanawa Y; Shibuya N; Shirakabe K; Higashiyama M; Kurihara C; Watanabe C; Komoto S; Nagao S; Kimura K; Miura S; Shimizu K; Hokari R
    Gut Liver; 2019 May; 13(3):325-332. PubMed ID: 30602220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M; Hongo M; Fukudo S
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Gu X; Song LJ; Li LX; Liu T; Zhang MM; Li Z; Wang P; Li M; Zuo XL
    Front Microbiol; 2020; 11():1281. PubMed ID: 32733392
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of nesfatin-1 in a rat model of visceral hypersensitivity.
    Jia FY; Li XL; Li TN; Wu J; Xie BY; Lin L
    World J Gastroenterol; 2013 Jun; 19(22):3487-93. PubMed ID: 23801843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota.
    Jin Y; Ren X; Li G; Li Y; Zhang L; Wang H; Qian W; Hou X
    J Gastroenterol Hepatol; 2018 Feb; 33(2):443-452. PubMed ID: 28573746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets.
    Kim GH; Lee K; Shim JO
    Microbiol Spectr; 2023 Feb; 11(1):e0212522. PubMed ID: 36652592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.